RxDoctor Payments Data

Rhyne Dengenis, DO

Orthopaedic Surgery · Massapequa, NYNPI 1144663667

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,001 of the $4,186 with a category attached, or 71.7%. 18 manufacturers reported payments, led by Gotham Surgical Solutions & Devices, Inc. at 31.5% of the total. Reporting peaked in 2019 at $1,595 and has fallen 97.6% since, to $38 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.

$4,186in general payments, 2019–2025

Across 50 payments — averaging $83.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Arteriocyte Medical Systems, Inc.$809
  • Johnson & Johnson$577
  • Stryker$379
  • Amgen$263
  • Smith+Nephew$181
  • plus $659 from 12 others

What the payments were for

  • Food & beverage$3,00172%
  • Education$1,18528%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,186 in reported general payments places this provider in the 50th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$319,039
Medicare patients
723
Services billed
7,068

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib59$594
Diclofenac Sodium56$483
Meloxicam177$451
Ondansetron Hcl26$75
Oxycodone Hcl29$58

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Massapequa

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →